Skip to content
naulon
Not checkedNot checked for notices yet.

Pediatric pulmonary mucormycosis in a diabetic patient treated with extended pleurectomy and Clagett procedure

Rebecca C. Gologorsky, Sora Ely, Kara A. Rothenberg and 2 more

Journal of Pediatric Surgery Case Reports · 2019

doi:10.1016/j.epsc.2019.101210 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Mucor is a ubiquitous fungus that is non-pathogenic in healthy people. In immunocompromised hosts, nonfunctional or absent neutrophils and macrophages result in fungal invasion and infection [1]. Invasive mucor (mucormycosis) most commonly involves the sinuses, brain, or lungs. Pulmonary mucormycosis typically presents in patients with a history of organ transplantation or hematologic malignancy [2], and is rare in patients with diabetes alone. The epidemiology and management of pediatric pulmonary mucormycosis is poorly described. We report an unusual occurrence of this disease, complicated by segmental pulmonary artery thrombus in a 15-year-old with poorly controlled diabetes. His severe, medication-resistant infection was ultimately treated successfully with antifungal medication combined with aggressive surgical debridement. The pulmonary artery segmental thrombus resolved after treatment of the underlying infection without anticoagulation. Keywords: Mucormycosis, Pulmonary mucormycosis, Diabetes, Pneumonectomy, Clagett procedure, Pediatric thoracic surgery

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.